{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:06:28Z","timestamp":1787069188441,"version":"build-2736575974"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Middle East Afr J Ophthalmol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0974-9233.63069","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T01:51:24Z","timestamp":1274147484000},"page":"113","source":"Crossref","is-referenced-by-count":15,"title":["Noncosmetic periocular therapeutic applications of botulinum toxin"],"prefix":"10.4103","volume":"17","author":[{"given":"Pelin","family":"Kaynak-Hekimhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-9233.63069-1","first-page":"924","volume-title":"Pharmacologic weakening of extraocular muscles","author":"Scott","year":"1973","journal-title":"Invest Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-2","doi-asserted-by":"crossref","unstructured":"Clark RP, Berris CE. Botulinum toxin: A treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg 1989;84:353-5.","DOI":"10.1097\/00006534-198908000-00027"},{"key":"key-10.4103\/0974-9233.63069-3","first-page":"197","volume-title":"Botulinum toxin (botox) chemodenervation for facial rejuvenation","author":"Carruthers","year":"2001","journal-title":"Facial Plast Surg Clin North Am"},{"key":"key-10.4103\/0974-9233.63069-4","first-page":"85","volume-title":"BOTOX use in the mid and lower face and neck","author":"Carruthers","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"key-10.4103\/0974-9233.63069-5","first-page":"71","volume-title":"Botulinum toxin type A: History and current cosmetic use in the upper face","author":"Carruthers","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"key-10.4103\/0974-9233.63069-6","first-page":"241","volume-title":"Chemodenervation for facial dystonias and wrinkles","author":"Harrison","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-7","first-page":"221","volume-title":"Botulinum toxin a in the treatment of blepharospasm: A 10-year experience","author":"Silveira-Moriyama","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"key-10.4103\/0974-9233.63069-8","doi-asserted-by":"crossref","unstructured":"Mauriello JA Jr, Dhillon S, Leona T, Pakeman B, Mostafavi R, Yepez MC. Treatmentselections of 239 patients with blepharospasm and Meige syndrome over 11 years Br J Ophthalmol 1996;80:1073-6.","DOI":"10.1136\/bjo.80.12.1073"},{"key":"key-10.4103\/0974-9233.63069-9","first-page":"687","volume-title":"Botulinum toxin type B in blepharospasm and hemifacial spasm","author":"Colosimo","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0974-9233.63069-10","first-page":"279","volume-title":"Botulinum toxin in ophthalmic plastic surgery","author":"Naik","year":"2005","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0974-9233.63069-11","doi-asserted-by":"crossref","unstructured":"Frueh BR, Felt DP, Wojno TH, Musch DC. Treatment of blepharospasm with botulinum toxin: A preliminary report. Arch Ophthalmol 1984;102:1464-8.","DOI":"10.1001\/archopht.1984.01040031184014"},{"key":"key-10.4103\/0974-9233.63069-12","first-page":"64","volume-title":"Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of patients with blepharospasm and hemifacial spasm","author":"Cakmur","year":"2002","journal-title":"J Neurol"},{"key":"key-10.4103\/0974-9233.63069-13","first-page":"54","volume-title":"Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye","author":"Horwath-Winter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-14","first-page":"1843","volume-title":"Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening","author":"Forget","year":"2002","journal-title":"Neurology"},{"key":"key-10.4103\/0974-9233.63069-15","first-page":"387","volume-title":"Chemodenervation in treatment of upper eyelid retraction","author":"Ozkan","year":"1997","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0974-9233.63069-16","first-page":"528","volume-title":"Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease","author":"Olver","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-17","first-page":"1183","volume-title":"Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection","author":"Uddin","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.63069-18","first-page":"181","volume-title":"Botulinum toxin type a for dysthyroid upper eyelid retraction","author":"Morgenstern","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0974-9233.63069-19","unstructured":"Allergan (2005) BOTOX\u037e COSMETIC (botulinum toxin type A) purified neurotoxin complex. Available from: http:\/\/www.botoxcosmetic.com\/resources\/pi.aspx. [Last cited on 2007 April 11]."},{"key":"key-10.4103\/0974-9233.63069-20","first-page":"1893","volume-title":"Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.Dermatol Surg","author":"Brandt","year":"2009","journal-title":""},{"key":"key-10.4103\/0974-9233.63069-21","first-page":"964","volume-title":"Dose standardization of botulinum toxin","author":"Quinn","year":"1989","journal-title":"Lancet"},{"key":"key-10.4103\/0974-9233.63069-22","first-page":"6","volume-title":"A double blind, randomized, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","author":"Odergren","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0974-9233.63069-23","unstructured":"Lipham WJ. What is botulinum toxin and how does it work? Cosmetic and clinical applications of Botox and dermal fillers. In: Lipham WJ, editor. Thorofare NJ: Slack incorporated; 2004. p. 6-9."},{"key":"key-10.4103\/0974-9233.63069-24","doi-asserted-by":"crossref","unstructured":"Lipham WJ. Getting started, commercially available products, basic equipment and supplies, reconstitution and dilution recommendations and clinical implementations. Cosmetic and clinical applications of Botox and dermal fillers. In: Lipham WJ, editor. Thorofare NJ: Slack incorporated; 2004. p. 23-37.","DOI":"10.1201\/9781003523338-4"},{"key":"key-10.4103\/0974-9233.63069-25","first-page":"130","volume-title":"Efficacy of skin cooling and EMLA cream application for pain relief of periocular botulinum toxin injection","author":"Elibol","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0974-9233.63069-26","doi-asserted-by":"crossref","unstructured":"Wirtschafter JD. Clinical doxorubicin chemomyectomy: An experimental treatment for benign essential blepharospasm and hemifacial spasm Ophthalmology 1991;98;357-66.","DOI":"10.1016\/S0161-6420(91)32288-7"},{"key":"key-10.4103\/0974-9233.63069-27","first-page":"1665","volume-title":"Supramaximal doses of botulinum toxin for refractory blepharospasm","author":"Levy","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.63069-28","unstructured":"Y\u03cdld\u03cdr\u03cdm Y, Kaynak-Hekimhan P, Demirel B, Kaya V. Treatement of upper eyelid retraction with botulinum toxin A. presented at TOD 42. National Ophthalmology Congress 19-23 nov 2007 Belek, Antalya; 2007."},{"key":"key-10.4103\/0974-9233.63069-29","first-page":"56","volume-title":"Botulinum toxin applications in periocular pathologies (review)","author":"Kaynak-Hekimhan","year":"2007","journal-title":"Turkiye Klinikleri Cerrahi T\u03cdp Bilimleri Oftalmoloji (J Surg Med Sci)"},{"key":"key-10.4103\/0974-9233.63069-30","first-page":"466","volume-title":"A single transcutaneous injection with Botox for dysthyroid lid retraction","author":"Shih","year":"2004","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0974-9233.63069-31","first-page":"153","volume-title":"Botulinum toxin for the treatment of congenital entropion","author":"Christiansen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-32","first-page":"453","volume-title":"Duration of botulinum toxin effect in the treatment of crocodile tears","author":"Nava-Castaneda","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0974-9233.63069-33","first-page":"705","volume-title":"Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland","author":"Montoya","year":"2002","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0974-9233.63069-34","first-page":"43","volume-title":"Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation","author":"Keegan","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-35","first-page":"394","volume-title":"An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis","author":"Ellis","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-36","first-page":"213","volume-title":"Treatment of aberrant facial nerve regeneration with botulinum toxin A","author":"Chua","year":"2004","journal-title":"Orbit"},{"key":"key-10.4103\/0974-9233.63069-37","first-page":"129","volume-title":"Drug-induced acute angle closure glaucoma","author":"Lachkar","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-38","first-page":"208","volume-title":"Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids","author":"Matarasso","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"key-10.4103\/0974-9233.63069-39","doi-asserted-by":"crossref","unstructured":"Goldman MP. Festoon formation after infraorbital botulinum A toxin: A case report. Dermatol Surg 2003;29:560-1.","DOI":"10.1097\/00042728-200305000-00022"},{"key":"key-10.4103\/0974-9233.63069-40","doi-asserted-by":"crossref","unstructured":"Kaltreider SA, Keneddy RH, Woog JJ, Bradley EA, Custer PL, Meyer DR. Cosmetic oculofacial applications of botulinum toxin: A report by the American Academy of Ophthalmology. Ophthalmology 2005;112:1159-67.","DOI":"10.1016\/j.ophtha.2005.03.021"},{"key":"key-10.4103\/0974-9233.63069-41","first-page":"508","volume-title":"Quantification of the efficacy of botulinum toxin type A by digital image analysis","author":"Heckmann","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-9233.63069-42","first-page":"596","volume-title":"Botulinum toxin type a in the treatment of dermatochalasis: An open-label, randomized, dose-comparison study","author":"Cohen","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0974-9233.63069-43","first-page":"55","volume-title":"Browlift with botulinum toxin","author":"Huang","year":"2000","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/0974-9233.63069-44","first-page":"134","volume-title":"Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation","author":"Aristodemou","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0974-9233.63069-45","first-page":"1515","volume-title":"Dry eyes and superficial punctate keratitis: A complication of treatment of glabelar dynamic rytides with botulinum exotoxin A","author":"Northington","year":"2004","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/0974-9233.63069-46","first-page":"481","volume-title":"Effect of eyelid botulinum toxin injection on lacrimal drainage","author":"Sahlin","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-47","first-page":"1855","volume-title":"Severe botulism after focal injection of botulinum toxin","author":"Souayah","year":"2006","journal-title":"Neurology"},{"key":"key-10.4103\/0974-9233.63069-48","first-page":"11","volume-title":"Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications","author":"Borodic","year":"2007","journal-title":"Facial Plast Surg Clin North Am"},{"key":"key-10.4103\/0974-9233.63069-49","first-page":"213","volume-title":"Developement of resistance to botulinum toxin type A in patients with torticollis","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"key":"key-10.4103\/0974-9233.63069-50","first-page":"181","volume-title":"Response to botulinum toxin F in sreonegative botulinum toxin A: Resistant patients","author":"Greene","year":"1996","journal-title":"Mov Disord"},{"key":"key-10.4103\/0974-9233.63069-51","first-page":"947","volume-title":"The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A: \u03adnitial experiences","author":"Barnes","year":"2005","journal-title":"Eur J Neurol"},{"key":"key-10.4103\/0974-9233.63069-52","first-page":"912","volume-title":"[Pharmacological aspects of therapeutic botulinum toxin preparations]","author":"Dressler","year":"2006","journal-title":"Nervenarzt"},{"key":"key-10.4103\/0974-9233.63069-53","first-page":"62","volume-title":"Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands","author":"Berweck","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"key-10.4103\/0974-9233.63069-54","first-page":"51","volume-title":"Botulinum-A toxin in the treatment of craniocervical muscle spasms: Short- and long-term, local and systemic effects","author":"Dutton","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0974-9233.63069-55","first-page":"1617","volume-title":"Mouse diaphragm assay for detection of antibodies against botulinum toxin type B","author":"Dressler","year":"2005","journal-title":"Mov Disord"},{"key":"key-10.4103\/0974-9233.63069-56","first-page":"530","volume-title":"Foam during reconstitution does not affect the potency of botulinum toxin type A","author":"Trindade","year":"2003","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/0974-9233.63069-57","first-page":"1328","volume-title":"Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines","author":"Lizarralde","year":"2007","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/0974-9233.63069-58","first-page":"273","volume-title":"Questioning the need to use Botox within 4 hours of reconstitution: A study of fresh vs 2-week-old Botox","author":"Yang","year":"2008","journal-title":"Arch Facial Plast Surg"},{"key":"key-10.4103\/0974-9233.63069-59","first-page":"433","volume-title":"Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids","author":"Hui","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0974-9233.63069-60","first-page":"523","volume-title":"Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application","author":"Hexsel","year":"2003","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/0974-9233.63069-61","first-page":"S24","volume-title":"Proper dose, preparation, and storage of botulinum neurotoxin serotype A","author":"Anderson","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"key-10.4103\/0974-9233.63069-62","first-page":"186","volume-title":"Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline","author":"Kwiat","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0974-9233.63069-63","first-page":"875","volume-title":"Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: A double-blind, randomized controlled trial","author":"van","year":"2003","journal-title":"J Am Acad Dermatol"}],"container-title":["Middle East African Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:17:36Z","timestamp":1787066256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-9233.63069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"alternative-id":["63069"],"URL":"https:\/\/doi.org\/10.4103\/0974-9233.63069","relation":{},"ISSN":["0974-9233"],"issn-type":[{"value":"0974-9233","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}